Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
Sarah Moharem Elgamal, Honorary Clinical Senior Lecturer at University of Liverpool, EACVI Education Awards Task Force, Communications Committee Member, EACVI Chair of Web and Communication, EACVI Board Member, Deputy Chair of the Cardiac CT Sub-Committee of EACVI Certification and Accreditation Committee at European Society of Cardiology, Editorial Board at European Heart Journal – Imaging Methods and Practice, Adult Congenital Heart Disease and Imaging Cardiology Consultant at Liverpool Heart and Chest Hospital, Emerging Editorial Consultant Journal of American College of Cardiology: Cardiovascular Imaging, shared a post on X:
“Three new studies, simultaneously published in the European Heart Journal – Cardiovascular Imaging alongside ESC Congress 2026, highlight how cardiovascular imaging is moving beyond anatomy toward haemodynamics, molecular biology and earlier risk prediction.
- An MRI-based model offers a promising, non-invasive approach to estimating right atrial pressure—an important marker of right-sided filling pressure and systemic congestion.
- Hybrid (¹⁸F)GP1 PET/MR provides direct in-vivo evidence linking platelet activation and microvascular thrombosis with microvascular obstruction after STEMI. Notably, platelet activity extended beyond abnormalities visible on cardiac MR, suggesting a potentially targetable biological pathway.
- Longitudinal change in the left atrioventricular coupling index independently predicted incident HFpEF in the MESA cohort. An increase of 1.6% or higher per year identified participants with more than twice the adjusted risk of HFpEF.
Together, these studies show the growing potential of advanced imaging to measure pressure non-invasively, reveal active disease mechanisms and identify subclinical remodelling before heart failure develops.”
Title 1: Non-invasive estimation of right atrial pressure using magnetic resonance imaging: a development and validation study
Authors: Jef Van den Eynde, Xander Jacquemyn, Hannah Van Belle, Youri Bekhuis, Anastasia Fambri, Tom Dresselaers, Alexander Van De Bruaene, Jan Bogaert
Read the Full Article on European Heart Journal – Cardiovascular Imaging
Title 2: Platelet activation and thrombosis in microvascular obstruction
Authors: Craig Balmforth, Alessandro Giaj Levra, Beth Whittington, Aidan Morgan, Mark G Macaskill, Evangelos Tzolos, Alex J Jordan, Tariq Ramtoola, Tim Clark, Michelle Rooney, Christophe Lucatelli, Edwin J R van Beek, Piotr J Slomka, Stephanie L Sellers, Norman Koglin, Andrew W Stephens, Iris Hardewig, David E Newby, Michelle C Williams, Marc R Dweck
Read the Full Article on European Heart Journal – Cardiovascular Imaging
Title 3: Change in left atrioventricular coupling index predicts incident heart failure with preserved ejection fraction: the multi-ethnic study of atherosclerosis
Authors: Daniel J Lim, Malak Hoballah, Ashkan Abdollahi, Robyn L McClelland, Wendy Post, Theo Pezel, Steven Shea, David Bluemke, Bharath Ambale-Venkatesh, Joao A C Lima
Read the Full Article on European Heart Journal – Cardiovascular Imaging
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
-
Sep 6, 2026, 18:13Emilio Osorio: Can Anticoagulation Be Safely Discontinued After Surgical Left Atrial Appendage Occlusion?
-
Sep 6, 2026, 18:11Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
-
Sep 6, 2026, 18:10Chayakrit Krittanawong: Have You Heard of Blood Clots in the Legs?
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 16:41Christina (Tina) P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size
-
Sep 6, 2026, 16:23Kevin Buda: Many High-Risk PE Patients Have Contraindications to Thrombolysis